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ABSTRACT 
     Nitroimidazole is an antibiotic and radiosensitizer chemical with great potentials in 
imaging. The hepato-cytoxicity evaluation of nitroimidazole and possible energy status changes in 
liver cells due to its anti-inflammatory characteristics are crucial in tumor imaging and 
chemotherapy. Adenylate cyclase is key enzyme to cause energy imbalance leading to cytotoxicity. 
To evaluate energy status in hepatocytes and Kupffer cells, adenylate cyclase activities in isolated 
liver cells were compared in presence of stimulators. To evaluate the effect of effectors on 
adenylate cyclase in cultured hepatocyte cells, adenylate cyclase enzyme was stimulated by 
different GITP, GTP, progesterone and nitroimidazole effectors. In cultured Kupffer cells, 
prostaglandin E2 and F2 were used as effectors. The results showed that nitroimidazole decreased 
adenylate cyclase specific activity in dose-dependent manner after pre-incubation of hepatocytes 
with the nitroimidazole in medium. Nitroimidazole stimulated adenylate cyclase activities in 
hepatocytes were mediated by cAMP and determined by cAMP mesurement. The stimulatory 
effect of nitroimidazole on adenylate cyclase was independent of the GTP presence in the assay 
system perhaps due to a direct effect on the catalytic subunit of adenylate cyclase enzyme. In 
addition, basal cAMP generation in hepatocyte cells was efficiently suppressed by the 
nitroimidazole. In conclusion, nitroimidazole exhibits direct effect on the catalytic subunit of the 
adenylate cyclase system. The adenylate cyclase was hormone sensitive in liver cells. 
KEYWORD: progesterone, liver, radiosensitizer, bio-imaging, energy status  
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INTRODUCTION 
The cyclic AMP (cAMP) status in isolated hepatocytes and Kupffer cells from 
various animals has been reported to play as secondary messenger (Yang and Li 2003; 
Zhang, Liu, and Harbrecht 2003; Siu 2004). ATP/cAMP depleted ratio have been shown as 
initial event of energy insufficiency due to stimulated adenylate cyclase activity in isolated 
hepatocytes challenged by hormones and drugs (Di Fusco and Anand-Srivastava 2000; 
Radosavljevic, Todorovic, and Sikic 2004).  Moreover, hepatic reconditioning in the 
presence of oxygen prevents apoptosis to increase the tolerance to hypoxia using adenylate 
cyclase mediated adenosine release with interaction of adenosine A2A receptors (Carini et 
al. 2004). In this regard, guanylate cyclase was also reported to play an important role at 
low concentrations of nitric oxide (NO) to increase the resistance against cell killing and 
oxidative stress as cause of enhanced hepatic tolerance to hypoxia and reperfusion injury 
(Joshi, Ponthier, and Lancaster 1999; Nandagopal, Dawson, and Dawson 2001). However, 
the regulatory role of adenylate cyclase in hormone secretion was widely reported in rat 
hepatocytes.   Progesterone challenge to rat hepatocytes and its action over membrane 
receptor and binding with adenylate cyclase nucleotide component has been reported as 
two phase process (Ko, In, and Park-Sarge 1999). Activation and attenuation of adenylate 
cyclase due to GTP binding protein as messenger in membrane receptor-cyclase binding 
was reviewed (Van Dyke 2004; Kimura, Nakane, and Nagata 1987).    Guanine nucleotides 
have been shown to be required for adenylate cyclase stimulation by hormones and drugs 
(Skurat et al. 1985; Sanchez-Yague et al. 1994; Shpakov et al. 2005).   The present study 
extended the information that human hepatocytes have specific receptors for GITP, GTP 
and Kupffer cells have receptors for prostaglandin E2 and F2.  
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     Recently nitroimidazoles have been identified as potential anticancer agents with 
antibiotic and anti-inflammatory properties (Rossouw et al. 2005; Asikoglu et al. 2000). 
Till now no information is available on the nitroimidazole action over cyclic AMP status in 
isolated human hepatocytes.  We believe that cAMP may speculate the initial event of 
nitroimidazole cytotoxicity affecting the cyclic AMP dependent adenylate cyclase and its 
progesterone hormonal control. The positive correlation between the number of phenylated 
side-chains and phenolic rings of the imidazole molecule and the efficacy to inhibit 
adenylate cyclase activity appears due to the possible structure-activity relationship of 
nitroimidazole compound.  In present study, cultured control hepatocytes were compared 
with hepatocytes exposed with progesterone, GTP, and GITP to characterize their 
adenylate cyclase enzyme activities. Nitroimidazole-induced adenylate cyclase activity 
was analyzed as an indicator of hepatocytotoxicity of nitroimidazole. To establish 
stimulatory role of nitroimidazole on phagocytosis, the adenylate cyclase activities in 
Kupffer cells were analyzed in the presence of nitroimidazole, prostaglandins, and 
amoebic trophozoits. Our focus was to support the evidence of Gs protein-mediated and 
hormone-sensitive adenylate cyclase enzyme as cytoxicity marker. Other focus was to 
associate adenylate cyclase activity with nitroimidazole-induced amoebic resistance due to 
energy imbalance in Kupffer cells. Novelty of this report is that human liver adenylate 
cyclase showed effector-sensitive and hormone-sensitive nature. 
 
MATERIALS AND METHODS 
Human hepatocytes and Kupffer cell preparation: Human liver biopsies from 
amoebisis patients advised for liver biopsy (n=12) were collected by Menghini needle 
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inserting in three subsequent directions near the site of right lobe during aspiration of 
anchovy sauce as per guideline of human research protocol. These biopsy samples were 
taken out as by products for hepatocytes isolation, in petri dish in phosphate buffered 
solution containing HEPES buffer and treated with 0.05 % (w/v) Collagenase and 
Hylouronidase digestion in above buffer containing 5 mM  Ca++  for ten minutes.    All 
perfusion buffers were oxygenated with 100 % oxygen.  After perfusion, livers were 
excised, weighted, minced with rajor blade and placed with five volumes of ice cold 
perfusion solution and transferred in Potter-Elvehjem homogenizer.   Tissue was dispensed 
by hand with one or two strokes of a hard rubber pestle.  The pestle clearance was 2-3 mm.  
The dispensate was filtered through 100 micron mesh screen to remove aggregated cells.   
After filtration, dark grey cell suspension was placed in the beaker with bar magnet.   Bar 
magnet was moved for 45 minutes to separate hepatocytes.  The cells suspension was 
centrifuged at 50 x g for five minutes to precipitate hepatocytes.  These precipitated 
hepatocytes were washed three times by successive suspension.  For Kupffer cell isolation,  
supernatant left after hepatocytes was used for pronase in Kreb’s Hansleit buffer (1 mg/ml) 
digestion for isolating Kupffer cells (Kmiec 2001). Isolated hepatocytes and Kupffer cells 
were cultured for the experiments on effector stimulation and membrane adenylate cyclase 
activity measurement in hepatocyte and Kupffer cells.  However, whole hepatocytes and 
Kupffer cells were used instead of membranes due to lesser yield of parenchymal and 
nonparenchymal cells (Kmiec 2001). 
Enzyme preparations: Membrane enriched preparations used in adenylate cyclase assay 
were prepared as follows: hepatocytes were suspended in homogenization buffer and 
homogenized in Potter-Elvehjem homogenizer (1000 rpm 8 stokes ).  Homogenizer buffer 
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contained 0.01 M Tris HCl buffer pH 7.65 containing 1.0 mM dithiotritol.   The 
homogenate was filtered through cheesecloth and centrifuged at 1200 x g for 15 minutes to 
separate out membranes.  The membrane pallet was suspended in buffer and used in 
adenylate cyclase enzyme assays. 
Adenylate Cyclase assay: The enzyme reaction incubation mixture contained in total 0.2 
ml volume: 22 mM Tris HCl pH 7.65, 10 mM MgCl2 , 0.6 mM thiophyllin, 0.15 mg/ml of 
bovine serum albumin,  9 mM  phosphoenolpyruvate,  35 units/ml of pyruvate kinase,  1.0 
mM disodium cyclic AMP, 5.0 mM KCl,  22 mM ammonium sulphate,  0.25 mM 
dithiothritol, 1.0 mM ATP and 32P-ATP ( 2 x 106 cpm ).  Membrane preparations (50-100 
g membrane protein) were added to each sample.   After incubation for 15 minutes at 37 
0C, the reaction was terminated by putting tubes in boiled water for three minutes for each 
sample. Finally, the levels of   32P-radioactivity were measured as cyclic 32P-AMP as 
described elsewhere (Alvarez et al. 1995).  For standard, 2 x 106 cpm 32P-ATP showed 
32P-radioactivity as 80 cpm.   Protein concentrations were measured by the procedure of 
Lowry et al (Lowry et al. 1951). 
Isolated hepatocyte cultures and effectors: Hepatocytes in TC 199 cultures were 
maintained in falcon flasks under carbogen gas 95 % oxygen and 5 % carbon dioxide along 
with stimulators added as following: 
Group I: control hepatocyte cultures without any added effectors; 
Group II: hepatocyte cultures were maintained by incubating progesterone 5.0 mM with 
hepatocytes in group I cultures.   
Group III hepatocyte cultures were added with Entamoeba histolytica trophozoits 2 x 108 
cells/ml in group I cultures. 
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Group IV hepatocyte cultures were added with nitroimidazole stimulator added 10 g/ml 
in group I cultures. 
     These cultures were maintained in falcon flasks and after 48 hours incubation, 
relative adenylate cyclase activity was measured in nano moles per mg protein per 15 
minutes in harvested hepatocytes in presence of GTP and GITP stimulators. 
 
Isolated Kupffer cell cultures and effectors:  Kupffer cells in TC 199 cultures were 
maintained in falcon flasks under carbogen gas 95 % oxygen and 5 % carbon dioxide along 
with stimulations added as following: 
Group I: Control Kupffer cell cultures without any effectors. 
Group II: Kupffer cell cultures were added Entamoeba histolytica trophozoits 2 x 108 
cells/ml in group I cultures. 
Group III: Kupffer cell cultures were added nitroimidazole stimulator 10 g/ml in group I 
cultures. 
These cultures were maintained in falcon flasks and after 48 hours incubation, relative 
adenylate cyclase activity (in nano moles per mg protein per 15 minutes) and cAMP 
content (p moles/mg/min) were measured in harvested sticky Kupffer cells.  The activities 
of phosphodiesterase enzyme were measured as indicator of membrane integrity in each 
group.  The activities of prostaglandins E2 and F2 were measured in each group. 
 
RESULTS 
Control group hepatocyte cells showed baseline adenylate cyclase enzyme 
activities. The hepatocyte yield was (35 + 3) x 107 cells/ml as source livers were normal.    
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In these liver biopsies, the hepatocyte yield and adenylate cyclase activity are shown in 
Table 1.  The addition of stimulators altered the % yield of both liver cells.  Activity of 
adenylate cyclase enzyme is represented in both ways i.e. units per mg protein and units 
per 106 cells as shown in Figure 1.   The protein concentration in hepatocytes is represented 
as mg/ g wt from liver biopsies (Table 1). 
Adenylate Cyclase activity in hepatocyte cells was sensitive to additives. The 
enzyme activity was enhanced in the following order: progesterone < nitroimidazole < 
trophozoits as shown in Table 2.  The enzyme activity is represented as pmoles/mg/15 
minutes(units/mg). The stimulators GTP and GITP exhibited additive effect on adenylate 
cyclase sensitive to both amoebic trophozoits and nitroimidazole chemical agent. The 
nitroimidazole stimulated the adenylate cyclase enzyme activity and quantitative 
difference in different group was observed as shown in Figure 1.    
Progesterone in the presence of GTP in hepatocyte culture medium enhanced the 
enzyme activity 1.75 fold while progesterone in the presence of GITP also enhanced the 
enzyme activity but less than GTP addition.  It indicated that adenylate cyclase activity was 
hormone sensitive as well as nitroimidazole sensitive.  Other important feature of 
Entamoeba histolytica trophozoites induced hepatocyte behavior, showed increased the 
adenylate cyclase enzyme activity in hepatocytes.  Thus adenylate cyclase enzyme activity 
was nitroimidazole-sensitive and showed the enhanced enzyme activity as shown in Table 
2 in different cultured hepatocyte groups.    
Both GTP and GITP stimulators also showed the enhanced adenylate cyclase 
enzyme activity.   However, GITP enhanced adenylate cyclase activity was more than that 
of GTP induced enzyme activity. The addition of trophozoits enhanced the adenylate 
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cyclase activity in hepatocytes and GITP or GTP stimulatory effects both.  The 
progesterone addition in medium also enhanced the adenylate cyclase enzyme activity.  
The hepatocyte cultures with progesterone in medium showed 33 % increase in the 
adenylate cyclase enzyme activity over basal activity.   
  The control group Kupffer cells showed baseline adenylate cyclase enzyme 
activities and their yield was (17 + 1.0) x 106 cells/ml in normal liver biopsies.   Adenylate 
cyclase activities from Kupffer cells were sensitive to the presence of both amoebic 
trophozoites and nitroimidazole chemical agent added in the culture media. The 
phosphodiesterase enzyme activities in Kupffer cells as index of energy turn over showed 
the significantly enhanced enzyme activity after addition of trophozoits and nitroimidazole 
at lesser extent.  The addition of prostaglandin E2 and prostaglandin F2 in Kupffer cell 
culture, showed the enhanced kupffer cell adenylate cyclase activities in the following 
order of additives trophozoites > nitroimidazole > control as shown in Figure 2. 
 
DISCUSSION 
Human liver cells are mainly parenchymal and non-parenchymal cells. The 
adenylate cyclase enzyme participates in the formation of cAMP from ATP catalyzed by 
phosphodiesterase enzyme. Phophodiesterase enzyme plays role as membrane integrity 
marker. The cAMP plays a regulatory roles as a secondary messenger in the synthesis of 
active proteins by enzyme protein kinase C (PKC) in the presence of effectors as 
represented in Figure 3. However, human hepatocytes lack Gs protein indicating the active 
role of Gs-GTP coupled -adrenergic receptors playing role in basal cAMP generation. 
The resulting excessive rise in intracellular cAMP leads to lots of fluid accumulation. The 
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role of intracellular cGMP in cultured hepatocytes is well understood to regulate cyclic 
GMP-dependent kinase as shown in Figure 4. However, the role of increased 
cAMP-dependent adenylate cyclase and phosphodiesterase are not well known. The role of 
prostaglandins and steroid hormones suggest the activation of adenylate cyclase as a 
biochemical mechanism of defense (Berstein, Pravosudov, and Kryukova 1995; Melien et 
al. 1988). Although liver cell separation is widely reported, human hepatocytes and 
Kupffer cells isolation and culture methods are still poorly reported.  Most of the reports 
are available on rat liver cells.  Isolated hepatocyte cultures have been known very 
promising tool for drug monitoring studies and enzyme regulatory studies (Elaut et al. 
2006). In present study, isolation and culture of hepatocytes by collagenase digestion, 
yielded sufficient number of heaptocytes comparable with the yield by other studies. 
However, the adenylate cyclase enzyme activities of human hepatocytes were lower than 
the earlier reported enzyme activity (Zippin et al. 2004). The present study shows the high 
yield of the viable hepatocytes and adenylate cyclase enzyme estimations.   We have 
attempted in present study to isolate hepatocytes by collagenase digestion, and Kupffer 
cells by pronase digestion to achieve high enzyme yield.  The cultured hepatocytes were 
viable and sufficient for enzyme estimations.  The number of hepatocytes isolated from 
liver biopsies was in the range of 108 cells/ml. The yield of Kupffer cells was in the range 
of 107 cells/ml. In recent years, human liver transplantation and liver cell reconditioning 
and replacement therapeutic techniques have become a promising tool. 
 
Adenylate cyclase regulatory properties: Adenylate cyclase enzyme in isolated 
hepatocytes has been reported as tool of regulatory studies of hormones, enzymes in the 
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presence of Gs bound receptors (Small et al. 2000).  Membrane adenylate cyclase activity 
is defined due to its multi-pass transmembrane protein made of two cytosolic segments as 
shown in Figure 4. These segments play active roles in association of Gs-GTP. The GTP 
induced Gs binding with adenylate cyclase can be a key mechanism of adenylate cyclase 
stimulation or inhibition during progesterone bound -adrenergic receptor (Sunahara et al. 
1997). The possible mechanism of adenylate cyclase activation or inhibition by 
progesterone is shown in Figure 4.   The membrane adenylate cyclase activity can be an 
indicator of membrane viability. However, the enzyme activity depends on the type and 
nature of effecter. The behavior of liver cells in culture in the presence of effectors may 
indicate the regulatory effect of stimulators in vivo.   However, in cultures, hepatocytes and 
Kupffer cells may likely experience different physiological environment different from in 
vivo.   In controlled liver cell culture conditions of medium, the liver cells showed 
adenylate cyclase stimulation in a specific manner by effectors such as progesterone, 
nitroimidazole, GTP, GITP, and prostaglandins (Aoshiba, Rennard, and Spurzem 1997). 
The receptors for prostaglandins interact with Gs subunits. Gs-GTP complex binds with 
-adrenalgic receptor made of seven subunits as shown in Figure 5. Binding of receptor 
with Gs-GTP protein inhibits adenylate cyclase activity and cAMP formation. The present 
study highlights the behavior of liver cells and the characteristic features of their cyclic 
AMP dependent adenylate cyclase regulatory system in culture. 
 
Progesterone modulation of adenylate cyclase activity: Progesterone modulates the 
activity of adenylate cyclase and adenylate cyclase response is hormone sensitive (Gilman 
1984). The progesterone stimulates the receptor activating the adenylate cyclase by 
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stimulatory Gs-GTP complex resulting with formation of cAMP.  Hepatocytes with 
progesterone added in medium exhibited the enhanced enzyme activity. The addition of 
GTP stimulator did not change the adenylate cyclase activity. In contrast, GITP stimulated 
cells exhibited an apparent adenylate cyclase activation. Unlike the adenylate cyclase 
enzyme activity in the presence of different effectors in stimulated hepatocytes, the rates of 
cyclic AMP production was delayed in control hepatocytes.  However, progesterone 
addition to hepatocytes did not exhibit significant delay in GITP stimulated adenylate 
cyclase activity.  Thus reason can be speculated that progesterone binds with stimulatory 
receptors on hepatocytes which lead to increase in intracellular cyclic AMP accumulation 
through adenylate cyclase activation via guinine nucleotide regulated mechanism 
(Cohen-Tannoudji et al. 1991). The Kupffer cells also showed similar guanine regulatory 
enzyme properties.  
The progesterone response of adenylate cyclase activity is a two phase process (Ko, In, and 
Park-Sarge 1999; Martin, Farndale, and Wong 1987). First, progesterone receptor and 
catalytic subunit (C complex) of adenylate cyclase occupy the place on membrane 
followed by Gs protein interaction with enzyme to make G protein C complex (Ko, In, 
and Park-Sarge 1999).   However, the addition of GITP stimulated the adenylate cyclase to 
a greater extent in hepatocytes more than pre-exposed hepatocytes to progesterone.  
Recently, G protein-enzyme complex formation by GTP/GITP stimulation has been 
reviewed (Niu et al. 2003).   
    To our present knowledge, present study represents first human hepatocyte 
adenylate cyclase regulatory properties and enzyme stimulation by nitroimidazole, 
progesterone, and GTP/GITP stimulators.   It suggests the possible Gs protein-GTP 
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complex formation as progesterone stimulation over adenylate cyclase stimulation. In the 
presence of progesterone, stimulation of adenylate cyclase is associated with 
phosphodiesterase activation indicating adenylate cyclase as hormone-sensitive. It 
corroborates with similar view originally reported immunosuppression in cultured 
hepatocytes due to high deoxycortisone from pregnanolone and hydroxylation (Houslay et 
al. 1992). However, Progesterone bound with adenylate cyclase is regulated by Gs-GTP 
complex of enzyme and possibly progesterone receptor from cell surface leads to dose 
dependent progesterone stimulation of hepatocyte adenylate cyclase in the presence of 
Mg2+ (Bockaert and Sebben-Perez 1983).  The adenylate cyclase stimulatory effects were 
effector specific and additive except nitroimidazole that did not alter GITP/GTP 
stimulations.  
 
Nitroimidazole stimulation of adenylate cyclase activity:  Nitroimidazole is recently 
emerged as anti-tumor and radiosensitizer compound.  It is used in tumor imaging, therapy 
and anti-amoebic applications. Nitroimidazole has phenolic rings and phenolic side chains 
as shown in Figure 6. So, it is obvious that the side chains interfere with the 
dephosphorylation of ATP by phosphodiesterase enzyme. It appears to result with 
inhibition of hepatocyte adenylate cyclase catalytic subunit function in the presence of 
nitroimidazole. The cytotoxicity of nitroimidazole is poorly studied and reported.  
However, its anti-amoebic effect has been proven to decrease hepatic and intestinal 
infection rate. The nitroimidazole is widely reported as single dose in treatment of amoebic 
liver abscess.  Moreover, nitroimidazole induced cytotoxic effect on human hepatocytes 
are still not known.  DNA strand breakage, energy regulatory enzymes, phagocytosis, and 
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immune response have been reported as nitroimidazole induced cytotoxic effects in 
animals (Zheng and Olive 1997; Whitaker and McMillan 1992; Singh, Nair, and Pradhan 
1991).   The role of nitroimidzole is understood to restore energy regulatory process 
involving adenylate cyclase, phosphodiesterase, cAMP formation in hepatocytes and 
reported as hormone and GTP specific in action.  The nitroimidazole derivatives inhibited 
anterior pituitary cell function apparently by their direct effect on the catalytic subunit of 
the adenylate cyclase holoenzyme (Stalla et al. 1989).  The nonparenchymal Kuffer cells 
play a significant role of phagocytosis sensitive to prostaglandins. Recently, 
nitroimidazole derivatives have been identified as anticancer potential agents.  Still the role 
of imidazoles as anticancer agent is not established (Anderson et al. 2006).    The present 
study indicates the association of imidazole ring structure with the cyclic AMP dependent 
adenylate cyclase catalytic subunit regulatory mechanism in liver cells.   
   The antimaoebic effect has been proven as effective for amoebic liver abscess as 
nitroimidazole single dose sufficiently decreasing the hepatic infection rate (Blessmann et 
al. 2003). In tinidazole treated animals, the phagocytosis, DNA-strand damage, and 
immune response studies are well known in animals in vivo (Katsitadze et al. 1990). Still it 
is not known if cytokines in immunopathology are affected by nitroimidazole. In this 
direction, the present study indicated the role of nitroimidazole to obstruct GTP or GITP 
(in medium) binding with adenylate cyclase enzyme catalytic unit and GTP/GITP 
receptors on enzyme active site corroborating with earlier study. The Gs protein can 
activate both adenylate cyclase and guanylate cyclase enzymes (Johnson and Corbin 1991). 
Recently, the role of guanulate cyclase activation was reported as a two-step mechanism: a 
conformational change by ATP in the presence of high Ca2+ concentrations (Yamazaki et 
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al. 2003).  It indicates the role of high Ca2+ concentrations on adenylate cyclase. 
 
GTP and GITP stimulation: Effect of GTP and GITP stimulators upon adenylate cyclase 
enzyme activity in hepatocyte membranes was characteristic.   The control hepatocytes 
with progesterone in medium exhibited the enhanced adenylate cyclase enzyme activity 
and delayed cAMP production. However, no effect was seen on GTP stimulated states.   In 
contrast, GITP stimulated state exhibited an apparent activation.    However, progesterone 
addition to hepatocyte cultures did not cause any significant delay in GITP stimulated 
enzyme activity.  Thus reason can be speculated that progesterone may bind with specific 
GTP and GITP receptors on hepatocyte membrane which lead to increased intracellular 
cyclic AMP accumulation through adenylate cyclase activation via guanine nucleotide 
regulated mechanism. Perhaps the adenylate cyclase catalytic site is sensitive to different 
effectors and appears occupied in different specific ways by different additives in 
hepatocyte cultures. 
The progesterone response of adenylate cyclase activity may be explained as 
two-phase process of G protein interaction.   First, progesterone receptor and catalytic 
subunit of adenylate cyclase occupy the place on hepatocyte membrane followed by 
second phase of G proteins interaction with C complex to make G protein-C complex.   
However GITP stimulates adenylate cyclase to a much greater extent in membranes 
pre-exposed to progesterone.  The role of G protein-C complex formation by GTP/GITP 
stimulation has been reviewed earlier (Johnson and Corbin 1991). 
 
Kupffer cell enzyme regulatory properties: In present study, the amoebic trophozoits were 
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added in cultured non-parenchymal liver cells to observe the enzyme phosphodiesterase 
changes in vivo in presence of protaglandins as regulatory effectors. However, the in vivo 
trophozoit infection induced adenylate cyclase enzyme changes were appreciably higher 
than earlier animal liver cell reports (Yamazaki et al. 2003). These animals suggested high 
rate of immunopathological changes and membrane damage in liver. Entamoeba 
histolytica infection seems to disrupt hepatocyte membrane as reported widely 
(Soid-Raggi, Torres-Marquez, and Meza 1998). Membrane adenylate cyclase activity 
serves as indicator of membrane integrity as drug-sensitive or effector sensitive. 
The present study shows 5’ nitroimidazole specific cytotoxicity due to adenylate 
cyclase stimulation.  as hormone sensitive. The adenylate cyclase stimulation was also 
hormone sensitive and possibly dependent on Gs protein interaction with subsequent 
stimulatory effect of GTP/GITP stimulators.   Progesterone bound with adenylate cyclase 
appears to be regulated by guanine nucleotide component of enzyme.   Possibly, the 
progesterone effects the -adrenergic receptors from hepatocyte cell surface leading to 
dose dependent progesterone stimulation of adenylate cyclase in hepatocytes. The 
stimulatory effects were effector-specific and additive while nitroimidazole altered 
GITP/GTP stimulation as minimal. 
In conclusion, the hepatocyte adenylate cyclase provides cAMP as a second 
messenger. The adenylate cyclase activity in membrane is progesterone hormone-sensitive 
through receptor in the presence of Gs-GTP complex. The interaction of Gs-GTP with 
adenylate cyclase catalytic subunit regulates the available cAMP. The nitroimidazole 
enhances adenylate cyclase stimulation as a result of its cytotoxicity and resistance to 
amoebic trophozoits. 
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Table 1: The yield of hepatocytes and Kupffer cells is represented in different liver 
biopsies as % yield and protein concentration (mg/g wt) in each liver cell preparation.  
These cells were used for mixing with different additives in control group I(no additive), 
group II(progesterone), group III(trophozoits), group IV(nitroimidazole) 
 
 
 
 
                                           % yield                              Protein concentration             
                               _______________________   _________________________   
Group                       Hepatocyte    Kupffer cell     Hepatocyte       Kupffer cell       
                                                                                                                                  
 
Group I                       85                       75                12.5+1.1            8.5+0.9       
                                                                                                                     
 
Group II                     71                        74                12.4+0.8            7.9+0.6         
                                                                                                                                            
 
Group III                   70                         64                11.9+1.2           6.9+0.8           
                                                                                                                              
 
Group IV                   75                         72                12.2+0.4           7.2+0.7                    
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Table 2: Adenylate cyclase activity in hepatocytes in cultures shows the  effect of 
stimulators on hepatocyte cultures in presence of different GTP and GITP stimulators.  
Adenylate cyclase activity is expressed in units (p moles/mg/15 minutes) in membrane 
enriched preparations in the presence of 0.01 mM GTP and GITP stimulators in hepatocyte 
cultures.  The calculation of activity/106 cells was based on determination that 1 gm liver 
was used for total hepatocyte protein and particulate membrane protein. The distribution of 
adenylate cyclase enzyme activity in hepatocytes (units/mg) is shown as *. 
 
 
 
 
 
                                                              Adenylate cyclase activity 
 Hepatocytes                                    ____________________  _____  Stimulators_____ 
                                                          Unit/mg       Unit/106 cells         GTP           GITP 
                                                      
 Group I                                                50+5*              1.1*                  75+2          77+3 
 (Control)                                                
 
 Group II                                               61+6*              1.3*                  80+5          81+8 
(Progesterone)                                       
 
 Group III                                              89+3*               1.4*                  95+8          93+8 
(trophozoites)                                         
 
 Group IV                                              82+7*               1.35*              85.5+7      89.7+6 
(nitroimidazole)                                     
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Table 3:  The effect of additives on cyclic AMP content in Kupffer cells is shown. The 
maximum effect was observed by adding trophozoites followed by nitroimidazole. 
Calcium dependent phosphodiesterase activity and secretion of prostaglandin E2 and F2α in 
isolated Kupffer cells is represented in presence of additives in Group I (control), Group 
II(trophozoits)  and  Group III(nitroimidazole). 
 
 
 
 
 
 
*Calcium dependent phosphodiesterase was measured based upon cyclic AMP before and 
after incubation with 3 micromoles MgCl2, 0.25 % Triton x 100 (w/v), 80 moles 
imidazole buffer pH 6.9, calcium ion 1.5 x 10-5 M for incubation with supernatants at 37˚C 
in presence time of assay, these harvested cells were frozen, treated with 2% HCl2 for 10 
minutes boiling, cooling and centrifuged at 3000 G for 5 minutes.  The resultant heated 
liver supernatants were used for assay.  The total extract represented activity in 3 x 106 
cells. 
 
**The above supernatant extracts were used for determination of prostaglandin E2, F2α and 
cyclic AMP measurements by scintillation counting.  Protaglandins were estimated by 
radioimmunoassay.  For cyclic AMP determination, above cells after harvesting exhibited 
8.5 + 0.9 mg/gm weight (group I); 7.9 + 0.6 mg/ gm weight (group II); 7.2 + 0.7 mg/gm 
weight (group III) protein concentration in isolated Kupffer cells.  The P values are denoted 
as + (P values < 0.05) for Group II vs Group I values. Data shown are mean + sd.   
 
 
 
 
                   Adenylate cyclase     cAMP content         calcium dependent         Prostaglandin (ng/106 cells)** 
Group         activity(AC*)           (p moles/mg/min)    phosphodiesterase*      ________________________          
                   (p moles/mg/                                             activity (p moles                  E2                            F2α 
                   15 minutes)                                               per 106 cells) 
 
Group I          28.5 + 2.1                 1.1 + 0.07               12.5 + 1.5                       2.3 + 0.4                 5.1 + 1.1 
(control)   
 
Group II         28.9 + 1.9                 2.6 + 0.9+               18.6 + 1.8+                      3.4 + 0.4+               8.7 + 0.9+ 
(trophozoites)             
 
Group III        32.4 + 3.1                 1.7 + 1.0                13.9 + 1.2                        2.9 + 0.7                7.5 + 1.6 
(nitroimidazole) 
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Figure 1: A schematic sketch of adenylate cyclase stimulation and cytotoxicity events 
represent the role of progesterone, GTP, GITP on cAMP production. The possible 
role of effectors on SOD and oxidative stress is shown leading to energy and 
oxygen insufficiency as inflammatory mechanisms. Solid lines represent 
stimulation effect and dotted lines represent inhibition effect of different effectors. 
Abbreviation: IKK; IB kinase kinase, NF-B; nuclear factor B, NF-B-IB; 
nuclear factor B-inhibitor B complex, NO; nitric oxide, iNOS; inducible nitric 
oxide synthase, SOD; superoxide dismutase, PKC; protein kinase C, GTP; 
guanosine triphosphate, GITP; guanylyl imidotriphosphate 
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Figure 2: The progesterone receptor-sensitive adenylate cyclase activation by Gs protein 
is shown to form cAMP in the presence of GTP. The effectors, GTP, and 
nitroimidazole enhance the adenylate cyclase activity in liver cells. 
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Figure 3: The possible role of GTP and GITP on adenylate cyclase is shown in four steps. 
The Gs and Gs proteins undergoes association and dissociation to make Gs protein 
active to activate adenylate cyclase. Step 1: Gs with GDP bound, Step 2: Contact of 
Gs with hormone-receptor complex, Step 3: Gs with GTP bound dissociates into  
and  subunits to make Gs-GTP to activate, Step 4: GTP bound to Gs is 
hydrolyzed. 
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Figure 4:  The adenylate cyclase activity in hepatocytes is shown. The protein 
concentration represents total hepatocyte cell protein/mg liver weight and 
particular membrane protein. The adenylate cyclase activity (AC) in hepatocytes 
was units/mg membrane protein. The GTP and GITP stimulators were added in the 
hepatocyte medium with different effectors: control  group (Group I), progesterone 
(Group II), trophozoits (Group III), and nitroimidazole (Group IV). The enhanced 
AC activity is shown in the following order of trophozoits > nitroimidazole > 
progesterone > control. 
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Figure 5:  The adenylate cyclase activity and cAmp content is shown in Kupffer cells. The 
prostaglandins E2 and E2 showed significant inhibition (shown as * and ** in 
Table 3). The nitroimidazole enhanced the adenylate cyclase activity (shown as +) 
while trophozoits did not alter it (perhaps due to phagocytic action). 
 
 
 
 
 
 
 
 
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
09
.2
85
0.
1 
: P
os
te
d 
4 
Fe
b 
20
09
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: The nitroimidazole ring is shown to make active toxic radical causing 
hepato-cytotoxicity and adenylate cyclase activation. The mechanism of charge 
transfer on O=N-O- is represented as formation of toxic radical. 
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